Literature DB >> 10781854

Further development of the Helicobacter pylori mouse vaccination model.

P Sutton1, J Wilson, A Lee.   

Abstract

Immunisation against Helicobacter infection in mouse models has thus far produced neither complete protection against the bacteria, nor a complete prevention of the associated gastritis. This study aimed firstly to compare the sensitivities of the various methods used to assess H. pylori infection in the mouse model, and secondly to develop the experimental design to induce a more effective immunity, aimed at further reducing bacterial burden in the gastric tissue. Various mouse strains were prophylactically immunised with whole bacterial sonicate and cholera toxin before challenge with H. pylori-SS1. The relative sensitivities of the urease assay, histological assessment and the colony forming assay to detect levels of H. pylori colonisation were compared. Comparisons of different antigen doses and different timecourses of immunisation were performed. The colony forming assay was found to be far more sensitive than either the urease assay or histological assessment for determining the protective efficacies of immunisation. Mice which had 10(5) H. pylori per gram of stomach by colony assay were negative by histology and urease. Lower doses of whole cell sonicate were more protective than high doses and more effective immunisation was achieved by leaving at least 3 weeks between immunisation instead of weekly immunisations. In conclusion, for assessment of H. pylori colonisation in the mouse model, the colony forming assay should be used. The experimental protocol for immunisation has been altered to produce a significant improvement in protection. However, full protection has still not yet been achieved and more work is still required.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10781854     DOI: 10.1016/s0264-410x(00)00052-9

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  20 in total

1.  Protective efficacy of recombinant urease B and aluminum hydroxide against Helicobacter pylori infection in a mouse model.

Authors:  Rodolfo E Bégué; Halina Sadowska-Krowicka
Journal:  FEMS Immunol Med Microbiol       Date:  2010-08-23

2.  Assessment of Helicobacter pylori gene expression within mouse and human gastric mucosae by real-time reverse transcriptase PCR.

Authors:  B Rokbi; D Seguin; B Guy; V Mazarin; E Vidor; F Mion; M Cadoz; M J Quentin-Millet
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

3.  In vitro and in vivo activities of Chios mastic gum extracts and constituents against Helicobacter pylori.

Authors:  Sotirios Paraschos; Prokopios Magiatis; Sofia Mitakou; Kalliopi Petraki; Antonios Kalliaropoulos; Petros Maragkoudakis; Andreas Mentis; Dionyssios Sgouras; Alexios-Leandros Skaltsounis
Journal:  Antimicrob Agents Chemother       Date:  2006-11-20       Impact factor: 5.191

4.  Lactobacillus johnsonii La1 attenuates Helicobacter pylori-associated gastritis and reduces levels of proinflammatory chemokines in C57BL/6 mice.

Authors:  Dionyssios N Sgouras; Effrosini G Panayotopoulou; Beatriz Martinez-Gonzalez; Kalliopi Petraki; Spyros Michopoulos; Andreas Mentis
Journal:  Clin Diagn Lab Immunol       Date:  2005-12

5.  Oral immunization with recombinant Lactobacillus acidophilus expressing the adhesin Hp0410 of Helicobacter pylori induces mucosal and systemic immune responses.

Authors:  Fan Hongying; Wu Xianbo; Yu Fang; Bai Yang; Long Beiguo
Journal:  Clin Vaccine Immunol       Date:  2013-11-27

6.  Probiotics reduce bacterial colonization and gastric inflammation in H. pylori-infected mice.

Authors:  Kathene Candace Johnson-Henry; David J Mitchell; Yaron Avitzur; Esther Galindo-Mata; Nicola L Jones; Philip M Sherman
Journal:  Dig Dis Sci       Date:  2004-08       Impact factor: 3.199

7.  Absence of CD4+CD25+ regulatory T cells is associated with a loss of regulation leading to increased pathology in Helicobacter pylori-infected mice.

Authors:  S Raghavan; M Fredriksson; A-M Svennerholm; J Holmgren; E Suri-Payer
Journal:  Clin Exp Immunol       Date:  2003-06       Impact factor: 4.330

8.  CD8+ T cells are associated with severe gastritis in Helicobacter pylori-infected mice in the absence of CD4+ T cells.

Authors:  Mai Ping Tan; John Pedersen; Yifan Zhan; Andrew M Lew; Martin J Pearse; Odilia L C Wijburg; Richard A Strugnell
Journal:  Infect Immun       Date:  2007-11-19       Impact factor: 3.441

9.  Orally administered CpG oligodeoxynucleotide induces production of CXC and CC chemokines in the gastric mucosa and suppresses bacterial colonization in a mouse model of Helicobacter pylori infection.

Authors:  S Raghavan; J Nyström; M Fredriksson; J Holmgren; A M Harandi
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

10.  Generation of Helicobacter pylori ghosts by PhiX protein E-mediated inactivation and their evaluation as vaccine candidates.

Authors:  Klaus Panthel; Wolfgang Jechlinger; Alexander Matis; Manfred Rohde; Michael Szostak; Werner Lubitz; Rainer Haas
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.